Lamotrigin Dura (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels, which stabilises neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This action lowers neuronal hyper‑excitability, limiting the spread of abnormal electrical activity that causes seizures and contributing to mood‑stabilising effects in bipolar disorder.

The appropriate dose of lamotrigine is set by the prescribing clinician based on the patient’s age, indication, renal and hepatic function, and any concomitant medicines that may affect its metabolism. Dose titration is typically gradual to minimise the risk of skin reactions, and the exact regimen is individualized for each patient.

Data on lamotrigine use during pregnancy are limited, and the drug is classified according to local regulatory guidance. Clinicians weigh potential benefits against possible risks to the fetus. Lamotrigine does pass into breast milk, so breastfeeding mothers should discuss safety and monitoring with their healthcare provider.

To request Lamotrigin Dura, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lamotrigine is often compared with carbamazepine or valproic acid for seizure control. Unlike carbamazepine, lamotrigine has a lower risk of inducing hyponatraemia, but it requires slower titration to avoid rash. Compared with valproic acid, lamotrigine is less teratogenic but may be less effective for certain generalized seizure types, making choice patient‑specific.

Lamotrigin Dura should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Lamotrigin Dura is taken orally. The tablet should be swallowed whole with water and can be taken with or without food. Patients should follow the dosing schedule prescribed by their clinician and avoid crushing or chewing the tablet unless specifically instructed.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, aseptic meningitis, and rare blood disorders like agranulocytosis or aplastic anemia. Immediate medical attention is required if a rash spreads, blisters develop, fever occurs, or unexplained bruising or bleeding is observed.

Lamotrigine should be avoided in individuals with a known hypersensitivity to the drug or any of its components. Caution is also advised for patients with severe hepatic impairment, those taking interacting medications that markedly increase its levels, and pregnant women unless the therapeutic benefit outweighs potential risks.